Share this job

Trainee (Vet Biologicals and Emerging Therapies)

Selection procedure reference: EMA/TR/2184 

Deadline for applications: 15 July 2020 23:59 CET 


The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.


The 2020 Traineeship programme is now open for applications until 15 July 2020 23:59 CET, with an intake on 1 October 2020.


1. About the traineeship programme

The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students, who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.


Placement description

We are looking for a trainee to support the Veterinary Biologicals and Emerging Therapies Team.

Specific objectives and projects:

During your traineeship, you will participate in the implementation of the Veterinary Medicines Regulation (EU) 2019/6 (VMP-Reg).

The Veterinary Medicines Regulation (EU) 2019/6 (VMP-Reg) introduces for the first time the legal basis for granting marketing authorisations for products intended for limited markets with specific provisions, in order to promote the availability of VMPs within the Union for minor species or for the treatment or prevention of diseases that occur infrequently or in limited geographical areas.

The implementation of the new legal provisions will involve:
• the review of the approach for eligibility for ‘limited market’ product (establish objective criteria) to ensure that it is aligned with the intentions of the Regulation;
• the review and update existing technical guidance on reduced data requirements (safety, efficacy of all VMPs except immunologicals);
• continue ongoing work on MUMS classification and applying reduced data requirements and financial incentives in accordance with the agreed policy.

Learning outcomes:

We will help you to:

  • Increase knowledge about Veterinary Medicines Regulation.
  • Gain knowledge of the Agency’s processes and procedures in the area of authorisation of veterinary medicinal products, with specific focus on the authorisation of veterinary products intended for limited markets/availability of veterinary medicines.


Eligibility criteria

To be eligible for consideration for this placement, you are required to:

  1. enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
  2. possess a university degree in veterinary/pharmaceutical (minimum of three years or more) that must have been obtained within the last 12 months (July 2019 -July 2020) or be a university student on an Erasmus + or a similar programme or a PhD student.
  3. a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages

For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.

Behavioural Competencies

You will demonstrate the following behavioural competencies:

  • Communication skills
  • Interpersonal skills
  • Working with others
  • Adaptability
  • Research and analytical skills
  • Learning and development
Selection timelines

Deadline for applications

15 July 2020 23:59 CET

Assessments (remote)

From 20 July 2020 to 15 August 2020

Decision expected

By 15 August 2020

 Placement start

1 October 2020

Conditions of traineeship

The traineeship is offered for 10 months (1 October 2020 – 31 July 2021) and takes place at the Agency’s premises in Amsterdam. Traineeships are offered for either full-time or part-time (80% or 50%) combined with university studies.

The Agency pays a monthly stipend of €1,360 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining and leaving the Agency.

Each trainee will have a mentor at the Agency who will guide the trainee through the programme.

The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available here.



Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands

Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu


© European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged.